Adamantylamphetamines: evaluation of their activity on the central nervous system.
D000218:Adamantane / Q000031:analogs & derivatives / Q000494:pharmacology*; D000662:Amphetamines / Q000494:pharmacology* / Q000633:toxicity; D000818:Animals; D001952:Bridged-Ring Compounds / Q000494:pharmacology*; D002490:Central Nervous System / Q000187:drug effects*; D004353:Drug Evaluation, Preclinical; D005260:Female; D007928:Lethal Dose 50; D008694:Methamphetamine / Q000031:analogs & derivatives / Q000494:pharmacology; D051379:Mice
D000662:Amphetamines; D001952:Bridged-Ring Compounds; D008694:Methamphetamine; D000218:Adamantane